The aim of this project is to elucidate the physiological and pharmacological properties of mammalian presynaptic nerve terminals. Pinched-off terminals (synaptosomes) from rat brain are used for these studies. In one type of study, tracer 45Ca flux methods and fluorometric methods (with a Ca-sensitive fluorochromic indicator) will be employed to determine how the smooth endoplasmic reticulum (SER), mitochondria and the plasma membrane interact to help regulate the cytoplasmic free Ca2+ concentration, and to determine how these organelles respond to the changes in free Ca2+ that occur with neuronal activity. The resulting data should enable us to model these interrelationships accurately. In the second type of study, which comprises the major portion of the proposed program, the physiological, pharmacological and biochemical properties of the various potassium channels that are present in nerve terminals will be characterized. Tracer (86Rb) efflux studies will be used to determine the sensitivities of the K channels to various drugs and toxins; the channels will be incorporated into planar lipid bilayers to study the kinetic and pharmacologic properties of single K channels; the binding characteristics of K channel blockers and modulators will be investigated in synaptic membranes; the pharmacological properties will then be used to help identify the K channel proteins that will be isolated, characterized, and reconstituted into lipid bilayers to verify their functional integrity. The first K channel that will be investigated in this way is the non-inactivating, voltage-regulated K channel. This channel has been identified as the high-affinity phencyclidine (PCP) receptor (about 95,000 and 80,000 Dalton MW) in the brain. The results may help to explain how PCP induces a schizophrenia-like syndrome. We will then use similar methods to investigate the properties of a K channel that is activated by certain opiates.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS016106-12
Application #
3396696
Study Section
Physiology Study Section (PHY)
Project Start
1979-08-01
Project End
1991-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
12
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Song, Hong; Karashima, Eiji; Hamlyn, John M et al. (2014) Ouabain-digoxin antagonism in rat arteries and neurones. J Physiol 592:941-69
Song, Hong; Thompson, Scott M; Blaustein, Mordecai P (2013) Nanomolar ouabain augments Ca2+ signalling in rat hippocampal neurones and glia. J Physiol 591:1671-89
Blaustein, Mordecai P (2013) Livin' with NCX and lovin' it: a 45 year romance. Adv Exp Med Biol 961:3-15
Song, Hong; Lee, Moo Yeol; Kinsey, Stephen P et al. (2006) An N-terminal sequence targets and tethers Na+ pump alpha2 subunits to specialized plasma membrane microdomains. J Biol Chem 281:12929-40
Lee, Moo Yeol; Song, Hong; Nakai, Junichi et al. (2006) Local subplasma membrane Ca2+ signals detected by a tethered Ca2+ sensor. Proc Natl Acad Sci U S A 103:13232-7
Golovina, Vera A (2005) Visualization of localized store-operated calcium entry in mouse astrocytes. Close proximity to the endoplasmic reticulum. J Physiol 564:737-49
Lencesova, Lubomira; O'Neill, Andrea; Resneck, Wendy G et al. (2004) Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes. J Biol Chem 279:2885-93
Golovina, Vera A; Song, Hong; James, Paul F et al. (2003) Na+ pump alpha 2-subunit expression modulates Ca2+ signaling. Am J Physiol Cell Physiol 284:C475-86
Gonzalez-Serratos, Hugo; Chang, Ruzhang; Rozycka, Monika et al. (2003) Role of the T-system and the Na-K pump on fatigue development in phasic skeletal muscle. Adv Exp Med Biol 538:543-55; discussion 555
Blaustein, Mordecai P; Golovina, Vera A; Song, Hong et al. (2002) Organization of Ca2+ stores in vascular smooth muscle: functional implications. Novartis Found Symp 246:125-37; discussion 137-41, 221-

Showing the most recent 10 out of 62 publications